CAPE CLL

Watch as our CLL clinical advisor dives deeper into defining CLL, the clinical staging systems developed for this disease, and the role navigators play in the patient’s treatment journey.
Listen in as our CLL clinical advisor examines the “Watch and Wait” period in CLL and impact navigation can have during this period.
A look at understanding the complexities of mutations and cytogenetics in CLL, the role genetics plays in prognosis, and how navigators can educate their patients and caregivers.
An inspection of prognostic and predictive tools in CLL, risk categories, and impact on the patient’s treatment plan.
Our CLL clinical advisor examines indications for treatment in CLL for both symptomatic patients and asymptomatic patients as well as the navigator’s touchpoints during this phase.
Our CLL clinical advisor dives into the different targeted therapies for CLL patients including oral oncolytics and the impact navigation has on adherence to treatment and the multidisciplinary approach to care.
Take a look into possible treatment complications for CLL patients, barriers to adherence, and navigation strategies to improve compliance to treatment.
Watch as we examine the navigator’s influence on care coordination for the CLL patient with an emphasis on patient advocacy and shared decision-making.
Explore the psychosocial effect of a CLL diagnosis including financial toxicity and quality of life and dive deeper into the navigator’s role in meeting the patient’s psychosocial needs.
Learn about the role of caregivers in the CLL treatment journey and the challenges they face including financial concerns and caregiver burnout. We also examine compassion fatigue and burnout in the healthcare community.